"The Houston Cardiologists at Texas Cardiology Associates of Houston are the best in their field. Trust a Doctor with your heart & call us!"

During the past decade, Texas Cardiology Associates of Houston conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 1 clinical trials were completed, i.e. on average, 12.5% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Texas Cardiology Associates of Houston" #1 sponsor was "Zoll Medical Corporation" with 3 trials, followed by "Amgen" with 2 trials sponsored, "Abiomed Inc." with 1 trials sponsored, "Eisai Inc." with 1 trials sponsored and "Vifor (International) Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Texas Cardiology Associates of Houston" #1 collaborator was "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Texas Cardiology Associates of Houston" are "Cardiac Arrhythmia" (2 trials), "Heart Failure" (2 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "Cardiomyopathies" (1 trials) and "Cardiovascular Disease" (1 trials). Many other conditions were trialed in "Texas Cardiology Associates of Houston" in a lesser frequency.

Most popular intervention types in "Texas Cardiology Associates of Houston" are "Device" (4 trials), "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Arrhythmia Management System (AMS)" (2 trials), "Placebo" (2 trials), "Evolocumab" (1 trials), "Heart Rate Monitor Enhanced Treatment Optimization" (1 trials) and "IABP Intra-aortic balloon pump" (1 trials). Other intervention names were less common.

The vast majority of trials in "Texas Cardiology Associates of Houston" are 7 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Texas Cardiology Associates of Houston". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 2 completed trials in Texas Cardiology Associates of Houston, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Texas Cardiology Associates of Houston, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".